Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/32566Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wilson, MG | - |
| dc.contributor.author | DeMaio, P | - |
| dc.contributor.author | Wang, Q | - |
| dc.contributor.author | Gauvin, François-Pierre | - |
| dc.contributor.author | Alam, S | - |
| dc.contributor.author | Ahmad, A | - |
| dc.contributor.author | Bain, T | - |
| dc.contributor.author | Bhuiya, AR | - |
| dc.contributor.author | Drakos, A | - |
| dc.contributor.author | Sharma, K | - |
| dc.contributor.author | Whitelaw, S | - |
| dc.contributor.author | Lavis, JN | - |
| dc.date.accessioned | 2025-10-22T17:53:16Z | - |
| dc.date.available | 2025-10-22T17:53:16Z | - |
| dc.date.issued | 2021-01 | - |
| dc.identifier.citation | Wilson MG, DeMaio P, Wang Q, Gauvin FP, Alam S, Ahmad A, Bain T, Bhuiya A, Drakos A, Sharma K, Whitelaw S, Lavis JN. COVID-19 living evidence profile #1 (version 1): What is known about anticipated COVID-19 vaccine roll-out elements? Hamilton: McMaster Health Forum, 20 January 2021. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/32566 | - |
| dc.description.abstract | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and, if applicable, a scan of experiences from other countries and from Canadian provinces and territories, about anticipated COVID-19 vaccine roll-out elements in response to a decision-maker’s request. | en_US |
| dc.description.sponsorship | The COVID-19 Evidence Network to support Decision-making (COVID-END) is supported by an investment from the Government of Canada through the Canadian Institutes of Health Research (CIHR). | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartofseries | LEP 1.1; | - |
| dc.subject | COVID-19 | en_US |
| dc.subject | vaccine | en_US |
| dc.subject | roll-out | en_US |
| dc.title | COVID-19 living evidence profile #1 (version 1): What is known about anticipated COVID-19 vaccine roll-out elements? | en_US |
| Appears in Collections: | Living evidence profile | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| COVID-19 living evidence profile 1.1_What is known about anticipated COVID-19 vaccine roll-out elements (1).pdf | 520.49 kB | Adobe PDF | View/Open | |
| COVID-19 living evidence profile 1.1-appendix_What is known about anticipated COVID-19 vaccine roll-out elements (1).pdf | 1.6 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
